IL145835A0 - Expression products of genes involved in diseases related to cholesterol metabolism - Google Patents
Expression products of genes involved in diseases related to cholesterol metabolismInfo
- Publication number
- IL145835A0 IL145835A0 IL14583500A IL14583500A IL145835A0 IL 145835 A0 IL145835 A0 IL 145835A0 IL 14583500 A IL14583500 A IL 14583500A IL 14583500 A IL14583500 A IL 14583500A IL 145835 A0 IL145835 A0 IL 145835A0
- Authority
- IL
- Israel
- Prior art keywords
- genes involved
- diseases related
- expression products
- cholesterol metabolism
- cholesterol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9906587A FR2794131B1 (en) | 1999-05-25 | 1999-05-25 | GENE EXPRESSION PRODUCTS INVOLVED IN CONDITIONS ASSOCIATED WITH THE METABOLISM OF CHOLESTEROL |
US13945099P | 1999-06-16 | 1999-06-16 | |
PCT/FR2000/001426 WO2000071710A2 (en) | 1999-05-25 | 2000-05-25 | Expression products of genes involved in diseases related to cholesterol metabolism |
Publications (1)
Publication Number | Publication Date |
---|---|
IL145835A0 true IL145835A0 (en) | 2002-07-25 |
Family
ID=26234967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14583500A IL145835A0 (en) | 1999-05-25 | 2000-05-25 | Expression products of genes involved in diseases related to cholesterol metabolism |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1183350A2 (en) |
JP (1) | JP2003518918A (en) |
KR (1) | KR20020033627A (en) |
AU (1) | AU4931800A (en) |
BR (1) | BR0010916A (en) |
CA (1) | CA2371500A1 (en) |
HU (1) | HUP0203164A2 (en) |
IL (1) | IL145835A0 (en) |
MX (1) | MXPA01011882A (en) |
NO (1) | NO20015729L (en) |
WO (1) | WO2000071710A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4726302B2 (en) | 1999-03-15 | 2011-07-20 | ユニバーシティ オブ ブリティッシュ コロンビア | Methods and reagents for regulating ABC1 polypeptide and cholesterol levels |
JP2004522410A (en) * | 2000-08-01 | 2004-07-29 | アムジェン インコーポレーテッド | C3b / C4b complement receptor-like molecules and uses thereof |
AT413701B (en) * | 2001-11-06 | 2006-05-15 | Bmt Medizinische Forschung Und | STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF CDW92 |
JP5618172B2 (en) | 2007-01-05 | 2014-11-05 | 国立大学法人東京大学 | Diagnosis and treatment of cancer using anti-PRG-3 antibody |
CA2705509A1 (en) | 2007-11-14 | 2009-05-22 | Forerunner Pharma Research Co., Ltd. | Diagnosis and treatment of cancer using anti-gpr49 antibody |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0941366A2 (en) * | 1996-11-06 | 1999-09-15 | Whitehead Institute For Biomedical Research | Biallelic markers |
-
2000
- 2000-05-25 BR BR0010916-9A patent/BR0010916A/en not_active IP Right Cessation
- 2000-05-25 HU HU0203164A patent/HUP0203164A2/en unknown
- 2000-05-25 IL IL14583500A patent/IL145835A0/en unknown
- 2000-05-25 CA CA002371500A patent/CA2371500A1/en not_active Abandoned
- 2000-05-25 JP JP2000620087A patent/JP2003518918A/en not_active Withdrawn
- 2000-05-25 WO PCT/FR2000/001426 patent/WO2000071710A2/en not_active Application Discontinuation
- 2000-05-25 KR KR1020017015017A patent/KR20020033627A/en not_active Application Discontinuation
- 2000-05-25 EP EP00931354A patent/EP1183350A2/en not_active Withdrawn
- 2000-05-25 AU AU49318/00A patent/AU4931800A/en not_active Abandoned
- 2000-05-25 MX MXPA01011882A patent/MXPA01011882A/en unknown
-
2001
- 2001-11-23 NO NO20015729A patent/NO20015729L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2003518918A (en) | 2003-06-17 |
KR20020033627A (en) | 2002-05-07 |
CA2371500A1 (en) | 2000-11-30 |
NO20015729L (en) | 2002-01-22 |
WO2000071710A2 (en) | 2000-11-30 |
AU4931800A (en) | 2000-12-12 |
MXPA01011882A (en) | 2002-05-06 |
WO2000071710A3 (en) | 2001-05-17 |
NO20015729D0 (en) | 2001-11-23 |
HUP0203164A2 (en) | 2002-12-28 |
EP1183350A2 (en) | 2002-03-06 |
BR0010916A (en) | 2002-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2361568B (en) | Improvements in or relating to packaging/display of products | |
PL316200A1 (en) | Co-ordinated expression of genes in vivo | |
AU2001285047A1 (en) | Human genes and gene expression products | |
IL134842A0 (en) | Method of delivering genes to antigen presenting cells of the skin | |
AU2001238511A1 (en) | Cosmetics to support skin metabolism | |
AU5319499A (en) | Fatty acids to minimize cancer therapy side effects | |
EP1276754A4 (en) | Materials and methods relating to lipid metabolism | |
GB0014150D0 (en) | Improvements relating to computer graphics | |
IL145835A0 (en) | Expression products of genes involved in diseases related to cholesterol metabolism | |
AU2002219988A1 (en) | Compositions and methods relating to breast specific genes and proteins | |
AU2001244892A1 (en) | Improvements in and relating to honey based products | |
AU4329300A (en) | Human mesenchymal dnas and expression products | |
IL146237A0 (en) | Autotaxin variants and uses to treat diseases of metabolism | |
AU2001297741A1 (en) | Compositions and methods relating to breast specific genes and proteins | |
ZA200109129B (en) | Expression products of genes involved in diseases related to cholesterol metabolism. | |
AU2003252979A1 (en) | Improvements in or relating to the heating of products | |
AU2003226582A1 (en) | Use of beta-aminoisobutyric acid for the treatment of diseases linked to the accumulation of triglycerides and cholesterol | |
GB9910139D0 (en) | Improvements in and relating to fermented meat products | |
AU1520599A (en) | Somatic transfer of modified genes to predict drug effects | |
HK1045103A1 (en) | Therapeutic uses of bpi protein products in bpi-deficient humans | |
IL147071A0 (en) | Nucleic and proteinic acids corresponding to human gene abc1 | |
AU1576501A (en) | Methods to enhance and confine gene expression in cancer therapy | |
AU2352301A (en) | Gene expression in corneal diseases | |
IL145056A0 (en) | Expression of human alpha-fetoprotein in mammalian cells | |
GB9806081D0 (en) | Improvements relating to product displays |